Technology | January 13, 2012

Predictive Model Released to Help Prevent Congestive Heart Failure Hospitalizations

January 12, 2012 — Clinical analytics company Humedica announced the launch of a predictive analytic model that identifies patients at high-risk for a congestive heart failure (CHF) hospitalization.  Designed to enable providers to identify high-risk CHF patients before they have been hospitalized, this tool can help reduce hospital admissions among the sickest, most costly patients in America. 

Developed with clinical data pulled directly from the electronic medical record (EMR), the Humedica system is more accurate and timely than other predictive analytic tools based upon claims-based risk predictors.

“We are leveraging the power of millions of patient experiences in our data warehouse, and are providing highly predictive capabilities that identify CHF patients who would likely end up hospitalized without prior medical intervention,” said Paul Bleicher, Humedica’s chief medical officer.  “Humedica is empowering clinicians to target specific groups of high-risk CHF patients and intervene before their condition worsens.”

Mary Jane Hall, chief nursing executive at the Community Physician Network in Indiana said, “Adopting predictive analytics capabilities into our practices are a critical part of our clinical arsenal and a key ingredient in our ability to thrive in an accountable care reimbursement model. Clinically-powered tools that help us target certain patients with appropriate interventions to avoid sub-optimal outcomes before they occur enable us to take a bold step into the future of healthcare.” The Community Physician Network in Indiana is joined by other Humedica MinedShare users in accessing the CHF predictive model, and is in the process of rolling out the tool throughout its organization.

CHF is the most expensive and preventable cause of inpatient admissions in the United States, costing an estimated $35 billion per year. Heart failure affects nearly 5 million patients nationwide with 500,000 new cases diagnosed annually.  Despite well-known and highly effective interventions, 40 percent of all Medicare patients with CHF are readmitted within 90 days.

For more information: www.humedica.com

 

Related Content

Study Shows Multiple Benefits of Patient-to-Patient Connectivity in Familial Chylomicronemia Syndrome
News | Cardiac Diagnostics | August 07, 2018
Akcea Therapeutics Inc., an affiliate of Ionis Pharmaceuticals Inc., announced the publication of results from the...
Being Overweight May Change Young Adults' Heart Structure, Function
News | Cardiac Diagnostics | August 03, 2018
Even as a young adult, being overweight may cause higher blood pressure and thicken heart muscle, setting the stage for...
High Intensity Exercise in Teenagers Could Ward Off Heart Disease

Ultrasound image of the carotid artery. Lines in yellow were used to determine arterial diameter and stretching before and following exercise.

News | Cardiac Diagnostics | July 16, 2018
New research published in Experimental Physiology has indicated potential differences in heart health benefits of...
News | Cardiac Diagnostics | June 14, 2018
A team of researchers says it has linked sensitivity to an allergen in red meat to the buildup of plaque in the...
The blood of patients with familial chylomicronemia syndrome (FCS) can appear milky in color (lipemic) due to the buildup of fat in their body. Image courtesy of Akcea Therapeutics.

The blood of patients with familial chylomicronemia syndrome (FCS) can appear milky in color (lipemic) due to the buildup of fat in their body. Image courtesy of Akcea Therapeutics.

 

Feature | Cardiac Diagnostics | May 07, 2018 | Steven D. Freedman, M.D., Ph.D.
 
Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Diagnostics | January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
ERT Acquires iCardiac Technologies
News | Cardiac Diagnostics | December 19, 2017
ERT recently announced it has acquired iCardiac Technologies, a provider of centralized cardiac safety and respiratory...
Overlay Init